| Authors | Vicki Brower |
| Journal | The Lancet. Oncology
(Lancet Oncol)
Vol. 18
Issue 2
Pg. e66
(02 2017)
ISSN: 1474-5488 [Electronic] England |
| PMID | 28017663
(Publication Type: News)
|
| Chemical References |
- Antibodies, Monoclonal
- Antineoplastic Agents, Immunological
- Erlotinib Hydrochloride
- onartuzumab
|
| Topics |
- Antibodies, Monoclonal
(administration & dosage, adverse effects)
- Antineoplastic Agents, Immunological
(administration & dosage, adverse effects)
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Carcinoma, Non-Small-Cell Lung
(drug therapy, mortality, pathology)
- Clinical Trials, Phase III as Topic
- Erlotinib Hydrochloride
(administration & dosage)
- Humans
- Lung Neoplasms
(drug therapy, mortality, pathology)
- Randomized Controlled Trials as Topic
- Treatment Outcome
|
